The Delphi Process to Drive Progress in PALTC

The field of geriatric medicine has long struggled with a relative lack of evidence-based studies and data. Randomized, controlled pharmaceutical trials are rare in the vulnerable older adult population, and this is particularly apparent in the post-acute and long-term care setting. A prime example was one of the major antihypertensive studies, the Hypertension in the Very Elderly Trial (HYVET), which specifically excluded nursing home residents (N Engl J Med 2008; 358:1887–1898).